Biontech SE BNTX:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
92.25UNCH (UNCH)
Volume
5,288
Close
92.25quote price arrow down-0.72 (-0.77%)
Volume
425,147
52 week range
85.21 - 131.52
Loading...
  • Open92.90
  • Day High93.84
  • Day Low92.20
  • Prev Close92.97
  • 52 Week High131.52
  • 52 Week High Date04/14/23
  • 52 Week Low85.21
  • 52 Week Low Date03/20/24

Key Stats

  • Market Cap21.93B
  • Shares Out237.73M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta0.22
  • YTD % Change-12.59

KEY STATS

  • Open92.90
  • Day High93.84
  • Day Low92.20
  • Prev Close92.97
  • 52 Week High131.52
  • 52 Week High Date04/14/23
  • 52 Week Low85.21
  • 52 Week Low Date03/20/24
  • Market Cap21.93B
  • Shares Out237.73M
  • 10 Day Average Volume0.84M
  • Dividend-
  • Dividend Yield-
  • Beta0.22
  • YTD % Change-12.59

RATIOS/PROFITABILITY

  • EPS (TTM)39.99
  • P/E (TTM)2.31
  • Fwd P/E (NTM)-75.76
  • EBITDA (TTM)1.143B
  • ROE (TTM)4.62%
  • Revenue (TTM)4.134B
  • Gross Margin (TTM)84.29%
  • Net Margin (TTM)24.36%
  • Debt To Equity (MRQ)1.08%

EVENTS

  • Earnings Date05/06/2024
  • Ex Div Date06/02/2022
  • Div Amount2.1322
  • Split Date-
  • Split Factor-

Latest On Biontech SE

Profile

MORE
BioNTech SE is a Germany-based clinical-stage biotechnology company. The Company focuses on patient-specific immunotherapies for the treatment of cancer and other serious diseases. The Company is providing technologies including mRNA-based therapies, cell therapies, small molecules and antibodies, which can be utilized for specific purposes or can be even combined with each other in a synergistic manner. It also develops a broad product pipeline using different scientific...
Ugur Sahin M.D.
Chief Executive Officer, Member of the Management Board
Sierk Poetting Ph.D.
Chief Operating Officer, Member of the Management Board
Jens Holstein
Chief Financial Officer
Address
An der Goldgrube 12
Mainz
55131
Germany

Top Peers

SYMBOLLASTCHG%CHG
ILMN
Illumina Inc
137.32-1.36-0.98%
GMAB
Genmab A/S
29.91-0.72-2.35%
CRL
Charles River Laboratories International Inc
270.95+1.58+0.59%
INCY
Incyte Corp
56.97-0.15-0.26%
ALNY
Alnylam Pharmaceuticals Inc
149.45-4.94-3.20%